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'The Geneva serum is excellent!' Autonomy and Isolation in the Swiss Cantons During the Early Years of Diphtheria Serum: The Case of Geneva
Mariama Kaba
At the end of the nineteenth century, Switzerland did not possess its own national institute equivalent to the Institut Pasteur in France, and nor did it promote intensive research in competitive laboratories like in Germany. Thus, the development of Swiss diphtheria serum production took place independently in each canton as a function of local resources and enthusiasm. The study of the Geneva case offers an interesting illustration of this model of diphtheria serotherapy research and production.
1 After giving some information on the context of the surge of diphtheria in the region, this paper will show how the canton of Geneva succeeded in having the product accepted and how it developed medical and social measures allowing the production, distribution and quality control of the serum in a context of total autonomy and in the absence of any national support.
The diphtheria situation in Geneva around 1890
In Geneva, the introduction of the 'anti-diphtheritic' serum in the middle of the 1890s coincided with a pronounced preoccupation with diphtheria on the part of the canton. According to the statistics from the Geneva Cantonal Hospital, during the 1880s mortality due to diphtheria in the canton had been lower than in other European cities that published similar statistics. The situation changed abruptly in 1890, despite the conditions of hospitalization and treatment remaining essentially the same.
2 The prevalence of virulent strains of the diphtheria bacillus now became comparable to that seen in England, Paris, or the rest of Switzerland, with the number of deaths from the disease rising as a consequence. The proportion of life-threatening cases of diphtheria at the cantonal Hospital grew sharply in comparison to the cases where the ailment was characterized by a local respiratory disorder usually relieved by tracheotomy.
Furthermore, between the years 1890 and at least 1897, the cantonal Hospital -where most of the population of Geneva was treated -registered a larger number of cases of diphtheria than of other diseases, and the number of deaths became preoccupying. Between 1880 and 1889, the institution recorded an average of 22 diphtheria cases per year, and 7 deaths annually, while in 1890, there were 64 cases with 16 deaths. This surge of diphtheria reached its peak the following year with 114 cases and 31 deaths (see Table 6 .1).
Thus, in 1891 diphtheria accounted for 89 per cent of the mortality for the 'main acute infectious diseases' identified and recorded by the Hospital, covering essentially early-childhood diseases (smallpox, measles, scarlet fever, typhoid, diphtheria and erysipelas).
3 As can be seen in Figure 6 .1, the peak in the number of deaths from diphtheria in 1891 would not be reached again in the canton of Geneva before the end of the century, and has, of course, since then never returned to this level.
The epidemic of diphtheria sweeping through the country doubtless largely explains the high mortality from this disease in Geneva. Indeed, diphtheria mortality first rose in northern Switzerland between 1876 and 1880; then, between 1881 and 1885, it reached a dozen central cantons. The increase then became apparent in neighbouring cantons and finally reached Geneva starting in 1890, 4 which is precisely the moment when the local authorities became concerned about the issue.
The fight against smallpox, regarded as the most dangerous disease in Geneva, had long been the focus of sanitary interests for the cantonal authorities. Nevertheless in January 1891, diphtheria appeared for the first time on the order for the mandatory notification of infectious diseases in Geneva. The order was drawn up by Dr Alfred Vincent , medical director at the cantonal Bureau of Public Health, and mainly concerned infantile diseases (measles, scarlet fever, diphtheria or croup, whooping cough, infantile cholera, dysentery, typhoid fever, erysipelas, puerperal fever, and glanders). 5 The Bureau, which dealt with issues of public hygiene, had been created at the end of 1884, among other reasons to organize the fight against the epidemics of cholera and typhoid fever that were affecting various European cities including the predominantly urban canton of Geneva. In 1891, the Bureau set up the first cantonal bacteriology laboratory, which as we will see, played a significant role in the history of the anti-diphtheria serum in Geneva. Nevertheless it was not the Bureau, which depended on the Genevan authorities, that introduced the serum into the canton. 
